Director/PDMR Shareholding
Eurocell plc announced that on April 30, 2026, Chief Executive Officer William Truman was granted 830,353 nil-cost options to acquire ordinary shares under the Eurocell plc Performance Share Plan 2025. This transaction, conducted outside a trading venue, represents an initial notification of a director's shareholding under UK Market Abuse Regulation.
Select text to share a quote on X · sign in to keep highlights & notes in your ECEL notes
Eurocell plc (the "Company") announces that, on 30 April 2026, options were granted under the Eurocell plc Performance Share Plan 2025 to Will Truman, Chief Executive Officer.
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | William Truman |
| 2. | Reason for the notification | |
| a) | Position / status | PDMR (Chief Executive Officer) |
| b) | Initial notification / amendment | Initial Notification |
| a) | Name | Eurocell plc |
| b) | Legal Entity Identifier | 213800RH62IQ7S9OFQ55 |
| a) | Description of the financial instrument | Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 |
| b) | Nature of the transaction | Grant of a nil-cost option to acquire ordinary shares under the Eurocell plc Performance Share Plan 2025 |
| c) | Price(s) and volume(s) | Price(s) Volume(s) £nil (option price) 830,353 |
| e) | Date of the transaction | 30 April 2026 |
| f) | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.